IMPACT OF MIRABEGRON TREATMENT AND SYMPTOM SEVERITY ON WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH OVERACTIVE BLADDER

被引：1
|
作者：
De, G. [1 ]
Yang, H. [2 ]
Runken, M. C. [3 ]
Yan, Y. [1 ]
Kelkar, S. [1 ]
Bui, C. N. [3 ]
Xie, J. [1 ]
Wu, E. Q. [2 ]
机构：
[1] Anal Grp Inc, New York, NY USA
[2] Anal Grp Inc, Boston, MA USA
[3] Astellas Pharma US Inc, Northbrook, IL USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.923
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A183 / A184
页数：2
相关论文
共 50 条
  • [21] Impact of body mass index on treatment efficacy of mirabegron for overactive bladder in females
    Krhut, Jan
    Martan, Alois
    Zachoval, Roman
    Hanus, Tomas
    Svabik, Kamil
    Zvara, Peter
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 196 : 64 - 68
  • [22] ECONOMIC AND CLINICAL IMPACT OF MIRABEGRON COMPARED WITH ANTIMUSCARINICS FOR THE TREATMENT OF OVERACTIVE BLADDER IN CANADA
    Nazir, J.
    Wagg, A.
    Berling, M.
    McCrea, C.
    Faytoye, F.
    Ramos, B.
    Hakimi, Z.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S446 - S447
  • [23] The star study: Analysis of symptom severity and treatment response in overactive bladder
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 117 - 117
  • [24] Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada
    Hakimi, Zalmai
    Nazir, Jameel
    McCrea, Charles
    Berling, Malin
    Fatoye, Francis
    Ramos, Barbara
    Wagg, Adrian
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (06) : 614 - 622
  • [25] Impact of Mirabegron Administration on the Blood Pressure and Pulse Rate in Patients with Overactive Bladder
    Ito, Hidenori
    Matsuo, Tomohiro
    Mitsunari, Kensuke
    Ohba, Kojiro
    Miyata, Yasuyoshi
    MEDICINA-LITHUANIA, 2022, 58 (06):
  • [26] Psychiatric History and Overactive Bladder Symptom Severity in Ambulatory Urogynecological Patients
    Rogowski, Artur
    Krowicka-Wasyl, Maria
    Chotkowska, Ewa
    Kluz, Tomasz
    Wrobel, Andrzej
    Berent, Dominika
    Mierzejewski, Pawel
    Sienkiewicz-Jarosz, Halina
    Wichniak, Adam
    Wojnar, Marcin
    Samochowiec, Jerzy
    Kilis-Pstrusinska, Katarzyna
    Bienkowski, Przemyslaw
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [27] Hormonal influence on the effect of mirabegron treatment for overactive bladder
    Kallner, Helena Kopp
    Elmer, Caroline
    Andersson, Karl-Erik
    Altman, Daniel
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (12): : 1303 - 1306
  • [28] Profile of mirabegron in the treatment of overactive bladder: place in therapy
    Sharaf, Ala'a
    Hashim, Hashim
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 663 - 667
  • [29] IMPACT OF SOLIFENACIN ON SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, TREATMENT SATISFACTION, AND SYMPTOMS IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM VIBRANT
    Mitcheson, H. D.
    Roy, J. B.
    Gilmet, G.
    Marshall, T. S.
    Shannon, J. B.
    VALUE IN HEALTH, 2009, 12 (03) : A201 - A201
  • [30] OVERACTIVE BLADDER SYMPTOM SEVERITY IS NOT RELATED TO CYSTOMETRIC BLADDER CAPACITY
    Blaivas, Jerry
    Liang, Lorraine
    Weiss, Jeffrey P.
    Amirian, Michael
    Samaroo, Chandra
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 324 - 325
12345